Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
O137322-25g | 25g | In stock | $28.90 | |
O137322-100g | 100g | In stock | $86.90 | |
O137322-500g | 500g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $232.90 |
Intermediate in pyrimidine metabolism
Synonyms | Orotic acid | 65-86-1 | 6-Carboxyuracil | Oropur | Orodin | Orotonin | Orotyl | Orotonsan | Vitamin B13 | Whey factor | Oroturic | 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid | Uracil-6-carboxylic acid | Animal galactose factor | 6-Uracilcarboxylic acid | Molkensaeure | Oro |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Intermediate in pyrimidine metabolism. Increases hepatic triacylglycerol levels in vivo . Cardioprotective. |
Shipped In | Normal |
Grade | Moligand™ |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Orotic acid is a heterocyclic compound and an acid. It was once believed to be part of the vitamin B complex and was called vitamin B13, but it is now known that it is not a vitamin but is instead manufactured in the body by intestinal flora. Its salts, known as orotates, are sometimes used as mineral carriers in some dietary supplements, to increase their bioavailability. It is an intermediate in de novo pyrimidine biosynthesis that may be used to study the specificity and kinetics of orotate phosphoribosyltransferase (OPRT) which catalyzes the reversible phosphoribosyl transfer from 5′-phospho-α-d-ribose 1′-diphosphate (PRPP) to orotic acid, forming pyrophosphate and orotidine 5′-monophosphate (OMP). It may be used to study dependent cell signaling pathways and transcription regulation mechanisms that induce hepatic lipogenesis. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488179577 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488179577 |
IUPAC Name | 2,4-dioxo-1H-pyrimidine-6-carboxylic acid |
INCHI | InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11) |
InChi Key | PXQPEWDEAKTCGB-UHFFFAOYSA-N |
Canonical SMILES | C1=C(NC(=O)NC1=O)C(=O)O |
Isomeric SMILES | C1=C(NC(=O)NC1=O)C(=O)O |
WGK Germany | 3 |
RTECS | RM3180000 |
PubChem CID | 967 |
Molecular Weight | 156.1 |
Beilstein | 383901 |
PubChem CID | 967 |
---|---|
Wikipedia | Orotic_acid |
ChEBI | CHEBI:16742 |
CAS Registry No. | 65-86-1 |
ChEMBL Ligand | CHEMBL1235017 |
RCSB PDB Ligand | ORO |
DrugCentral Ligand | 3402 |
PubChem SID | 488179577 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2219769 | Certificate of Analysis | May 15, 2024 | O137322 |
G2219770 | Certificate of Analysis | May 15, 2024 | O137322 |
G2219771 | Certificate of Analysis | May 15, 2024 | O137322 |
G2219772 | Certificate of Analysis | May 15, 2024 | O137322 |
C2110011 | Certificate of Analysis | Dec 14, 2022 | O137322 |
C2110012 | Certificate of Analysis | Dec 14, 2022 | O137322 |
K2217186 | Certificate of Analysis | Nov 23, 2022 | O137322 |
A2423104 | Certificate of Analysis | Mar 30, 2022 | O137322 |
K2216310 | Certificate of Analysis | Mar 30, 2022 | O137322 |
C2204053 | Certificate of Analysis | Mar 14, 2022 | O137322 |
Solubility | Soluble in Sodium Hydroxide |
---|
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | RM3180000 |
1. Yongyan Yang, Gangying Feng, Jingfei Wang, Ruiting Zhang, Shuangling Zhong, Jia Wang, Xuejun Cui. (2023) Injectable chitosan-based self-healing supramolecular hydrogels with temperature and pH dual-responsivenesses. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 227 (1038). [PMID:36460241] |
1. Yongyan Yang, Gangying Feng, Jingfei Wang, Ruiting Zhang, Shuangling Zhong, Jia Wang, Xuejun Cui. (2023) Injectable chitosan-based self-healing supramolecular hydrogels with temperature and pH dual-responsivenesses. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 227 (1038). [PMID:36460241] |